Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-24-000026

Chief Medical Officer acquired 11,366 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Rodman David Malcom Chief Medical Officer 2024-06-11 Option exercise +5,017 $0.54 $2,709 83,380 D: show line 1 in the form
Rodman David Malcom Chief Medical Officer 2024-06-12 Option exercise +6,349 $1.08 $6,857 89,729 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Rodman David Malcom Chief Medical Officer 2024-06-11 Option exercise · Stock Option −5,017 35,121 D: show line 3 in the form
Rodman David Malcom Chief Medical Officer 2024-06-12 Option exercise · Stock Option −6,349 190,357 D: show line 4 in the form
Loading xslF345X05/wk-form4_1718314321.xml…